Chapter 4
Modes of action and toxicity pathways
Where can be the common target site of any organic chemicals and why?
What are the commonality and difference between pathway of p53 and estrogen?
Even though we test chemicals showing highly toxic effects in in vivo, it could happen that we observe relatively low toxicity from these chemicals in in vitro systems. What could be the reason?